FILING ANALYSIS · FRIDAY, NOVEMBER 13
INTEGRATED BIOPHARMA INC INBP — 8-K: Results of Operations and Financial Condition
negative
The company reported a net loss of $0.7 million and a 22% decrease in revenue compared to the same quarter last year, with operating loss of $1.0 million and diluted net loss per share of $(0.02).
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →